According to the draft papers, Macleods Pharmaceuticals' initial share sale is totally a Market (OFS) of as much as 6.05 crore shares by marketers. The public problem makes up fresh problem of equity shares aggregating approximately Rs 900 crore as well as an OFS aggregating approximately Rs 1,200...